New Research Platform Automates Clinical Trial Enrollment
Biotech operators can use the $100 monthly tool to automate data collection and shorten trial recruitment to 24 hours.
Updated on Oct. 28, 2026 in Remote Work

Live Poll
Do you trust the data collected from remote, decentralized health studies as much as clinical trials?
San Francisco-based Alethios Inc. launched a suite of decentralized research tools designed to automate participant onboarding, data collection, and device integration. The platform aims to accelerate clinical trial timelines by managing participant-reported outcomes and lab coordination remotely.
Why it matters
The platform addresses the logistical bottlenecks that often inflate research costs and extend study durations for biotech and health-tech firms. By automating administrative tasks and patient follow-ups, companies can potentially shorten trial cycles and improve data collection efficiency.
The Study Planner platform is priced at $100 per month, having facilitated five peer-reviewed papers and conference posters. In one recent saliva study, 127 of 144 participants provided usable samples, demonstrating the platform's reliability for remote data management.
The players
Alethios Inc.
A San Francisco-based developer of decentralized research data collection software for the health-tech industry.
PLT Health Solutions
A developer and marketer of science-backed ingredients for the consumer health and wellness sector.
The details
The platform utilizes a no-code integration system to manage diverse data inputs, including digital biomarkers, wearable devices, and at-home testing. It automates the operational burden of clinical research by handling participant reminders, lab coordination, compensation, and data cleaning. This structure allows researchers to conduct 12-week randomized, double-blind, placebo-controlled trials without the need for centralized site visits.
Timeline
June 2026: PLT Health Solutions partnered with Alethios to offer decentralized clinical trials.
Past year: The company observed seven studies enroll participants in under 24 hours.
October 28, 2026: Official publication of the latest company developments.
Market Landscape
This launch follows an industry-wide trend toward adopting decentralized clinical trials to bypass traditional site-based limitations. Alethios joins a competitive field of firms attempting to standardize remote data collection and patient monitoring for the biotech sector.
Operators in the clinical research space should evaluate their current study enrollment timelines against the 24-hour benchmarks achieved via platform automation. Companies should also assess whether transitioning to a no-code data collection model could reduce overhead costs currently tied to manual laboratory coordination.
The takeaway
Decentralized platforms are increasingly capable of replacing manual administrative labor in complex, long-term clinical trials. Operators should track the conversion rates of participant-reported outcomes in their next study phase to determine if automation tools improve sample quality.
Further reading
For more on the operational shifts in distributed teams and research, visit Remote Work.
Source note: This article includes information reported by NutraIngredients.
Live Poll
Do you trust the data collected from remote, decentralized health studies as much as clinical trials?





